Where did Jeffrey Beall’s List of Predatory Publishers Go?

In mid-January, there was a flurry of emails on several librarian discussions lists all sharing the same information – Jeffery Beall’s list of predatory publishers will no longer be available on his website.

According to several news items, it was Jeffrey Beall’s own decision to take down the list and cease publication of his well-known site. Mr. Beall had been compiling his list since 2008, publicizing the names of journals and publishers that could be considered outside of the realm of credible scholarly publishing.  There are also rumors circulating that Cabell’s might take over where Beall left off, however, this remains to be seen and so perhaps the subject of a future post.

Jeffrey Beall’s list was a good resource but one should not negate the benefits of seeking the guidance of a librarian when evaluating a journal or scholarly publisher. Should an author question the validity of a journal or have concerns that an invitation to publish might be from an unscrupulous publisher, they should be aware of where they can go for help. Librarians support the scholarly communication process and can assist researchers– whether they are just beginning their publishing careers or seasoned authors and beyond.

Continue reading

Job loss in Breast Cancer Patients, Watson for Oncology, Precision Medicine, and Cycle for Survival

Dr. Victoria Blinder recently led a study that followed 267 breast cancer patients at MSK throughout their treatment. Dr. Blinder’s team found that between 20 and 30 percent of women diagnosed with breast cancer will eventually lose their job due to their diagnosis. But what was even more troubling is that poor women were four times more likely to be jobless by the end of treatment. The biggest factor in this difference is workplace accommodations for women with higher-paid, salaried jobs, where low-income women are half as likely to have accommodating work environments.
Blinder V, et al. Women with breast cancer who work for accommodating employers more likely to retain jobs after treatment. Health Affairs. 2017 Feb 1;36(2):274-81.


“Watson for Oncology” is coming to the US! IBM’s partnership with MSK will go live at it’s first use in a US community hospital. Florida’s Jupiter Medical Center will be deploying this new artificial intelligence clinical decision support tool. Currently Watson can assist clinicians with six different cancer types, and IBM and MSK are working to add an additional seven types in 2017. Watson for Oncology has already been in use in hospitals in Thailand, South Korea, and India.


The future of precision medicine was outlined in a report in Cell by MSK doctors David Hyman, Barry Taylor and José Baselga. According to the authors, this report is a roadmap for future efforts in cancer care. One of the hurdles the team addressed is that of a “engineering problem” which limits information sharing between the two vital role players, the researchers, and the clinicians.
Hyman, David M. et al. Implementing Genome-Driven Oncology. Cell 2017 Feb 9; 168(4):584-99


The11th Annual Cycle for Survival season is underway in the tri-state!
The Goodman family announced late last month that over $11 million has been raised already for the 2017 Cycle for Survival season, well on its way to surpassing last year’s record of $30.5 million by April. This year Cycle of Survival has events in 16 cities, including 17 events just in NYC.

What’s Not to Love About #OncoImmunology Being Added to Our Collection?

Due to user request, the Library has recently added a subscription to OncoImmunology from @tandfnewsroom! Published monthly, OncoImmunology deals specifically with the fundamental, translational and clinical areas of tumor immunology. Articles dealing with solid or hematological cancers, inflammation, innate and acquired immune responses are also published. Submissions of Original Research Articles, Brief Reports, Reviews, Commentaries and Meeting Reports in these area of research are welcome, and authors interested in publishing with the journal should consult their instructions page.

OncoImmunology may be found in our eJournal A-Z list or by searching TriCat, our Library catalog.